Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-10-09

Clinical Trial Update: Long Term Study Of Amlodipine 10mg With Hypertension For Whom Amlodipine 5mg Is Insufficient [Phase 3]

View source ↗

Summary

This document reports results from a Phase 3 long-term trial of amlodipine 10 mg for hypertension in patients not adequately controlled on 5 mg.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NORVASC (amlodipine besylate)

Snippet

Sponsor: Pfizer | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2009-10-09